While standard therapies, such as glucocorticoids, beta-2 adrenergic receptor (2AR) agonists, and biologics (e.g., anti-IgE, anti-IL-5, anti-IL5R, anti-IL4R) are effective in T2 high asthma, their efficacy is often diminished or non-existent in T2 low or metabolically driven asthma phenotypes
Description Why 5-Amino-1MQ Is Redefining Lipid Metabolism Research Selective NNMT inhibitor -35% fat mass in 11 days without appetite reduction (preclinical model) Enzymatic Target NNMT Inhibitor Selective inhibition of nicotinamide N-methyltransferase (IC50 = 1.2 M)
Although these peptides are still under investigation and not approved for human use, research models suggest several potential biological roles
When a single category of drug seems to reach from "recover better at the gym" all the way to "maybe help with something we have never solved," it is no wonder the internet cannot stop talking
No acute effects of exogenous glucose-dependent insulinotropic polypeptide on energy intake, appetite, or energy expenditure when added to treatment with a long-acting glucagon-like peptide 1 receptor agonist in men with type 2 diabetes
While improper use can cause temporary irritation, the skin heals readily once the irritant is removed
